Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CPI-431-32 as a potential new treatment for HBV/HCV and HIV-1 coinfection

April 28, 2015

Preclinical activity of BLU-554 prompts plans for a phase I trial

April 28, 2015

SignalRx Pharmaceuticals discloses dual PI3K/BRD4 inhibitors

April 28, 2015

Basmisanil has effects on EEG in subjects with Down syndrome

April 28, 2015

Scientists disclose new data on the effects of lorcaserin

April 28, 2015

Incyte presents the novel BET inhibitor INCB-054329

April 28, 2015

Dose-finding data from phase I study of AZD-8186 reported

April 28, 2015

First clinical results on antibacterial OP-0595

April 27, 2015

In vitro test first to detect psychiatric adverse events of drugs

April 27, 2015

Lack of mitochondrial toxicity of AL-335 and AL-516

April 27, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...